[go: up one dir, main page]

NO20071805L - Alkylidentetrahydronaphthalene derivatives, processes for their preparation and their use as inflammatory inhibitors. - Google Patents

Alkylidentetrahydronaphthalene derivatives, processes for their preparation and their use as inflammatory inhibitors.

Info

Publication number
NO20071805L
NO20071805L NO20071805A NO20071805A NO20071805L NO 20071805 L NO20071805 L NO 20071805L NO 20071805 A NO20071805 A NO 20071805A NO 20071805 A NO20071805 A NO 20071805A NO 20071805 L NO20071805 L NO 20071805L
Authority
NO
Norway
Prior art keywords
preparation
derivatives
alkylidentetrahydronaphthalene
processes
inflammatory inhibitors
Prior art date
Application number
NO20071805A
Other languages
Norwegian (no)
Inventor
Werner Skuballa
Stefan Jaroch
Konrad Krolikiewicz
Heike Schacke
Markus Berger
Stefan Baurle
Hartmut Rehwinkel
Duy Nguyen
Norbert Schmees
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of NO20071805L publication Critical patent/NO20071805L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)

Abstract

Oppfinnelsen vedrører alkyliden-tetrahydronaftalenderivater med generell formel (I) fremgangsmåte for deres fremstilling og deres anvendelse som antiinflammatoriske midler.This invention relates to alkylidene-tetrahydronaphthalene derivatives of the general formula (I) method for their preparation and their use as anti-inflammatory agents.

NO20071805A 2004-09-09 2007-04-03 Alkylidentetrahydronaphthalene derivatives, processes for their preparation and their use as inflammatory inhibitors. NO20071805L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004044680A DE102004044680B3 (en) 2004-09-09 2004-09-09 Alkylidene tetrahydronaphthalene derivatives, process for their preparation and their use as anti-inflammatory agents and pharmaceutical compositions containing them
PCT/EP2005/009623 WO2006027236A1 (en) 2004-09-09 2005-09-02 Alkylidene tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents

Publications (1)

Publication Number Publication Date
NO20071805L true NO20071805L (en) 2007-06-07

Family

ID=35517445

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071805A NO20071805L (en) 2004-09-09 2007-04-03 Alkylidentetrahydronaphthalene derivatives, processes for their preparation and their use as inflammatory inhibitors.

Country Status (25)

Country Link
EP (1) EP1786823B1 (en)
JP (1) JP2008512416A (en)
KR (1) KR20070050469A (en)
CN (1) CN101065386A (en)
AR (1) AR050733A1 (en)
AT (1) ATE384069T1 (en)
AU (1) AU2005281859A1 (en)
BR (1) BRPI0515186A (en)
CA (1) CA2577861A1 (en)
DE (2) DE102004044680B3 (en)
EA (1) EA200700550A1 (en)
EC (1) ECSP077306A (en)
ES (1) ES2301056T3 (en)
GT (1) GT200500241A (en)
IL (1) IL181832A0 (en)
MX (1) MX2007002833A (en)
NO (1) NO20071805L (en)
PA (1) PA8644701A1 (en)
PE (1) PE20060596A1 (en)
RS (1) RS20070095A (en)
SV (1) SV2006002220A (en)
TW (1) TW200621703A (en)
UY (1) UY29109A1 (en)
WO (1) WO2006027236A1 (en)
ZA (1) ZA200701399B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7638515B2 (en) 2003-10-08 2009-12-29 Bayer Schering Pharma Aktiengesellschaft Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US7662821B2 (en) 2003-10-08 2010-02-16 Bayer Schering Pharma Ag Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
DE502004002403D1 (en) 2003-10-08 2007-02-01 Schering Ag TETRAHYDRONAPHTHALIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS AN INFLAMMATORY INHIBITION
US20080153859A1 (en) 2004-04-05 2008-06-26 Hartmut Rehwinkel Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
DE102004063227A1 (en) * 2004-12-22 2006-07-06 Schering Ag Tricylic amino alcohols, process for their preparation and their use as anti-inflammatory agents
EP1834948A1 (en) 2006-03-15 2007-09-19 Bayer Schering Pharma Aktiengesellschaft Tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiinflammatory drugs
EP1917963A1 (en) * 2006-10-31 2008-05-07 Bayer Schering Pharma Aktiengesellschaft Cyclic phenyl-substituted indazols, a process for their production and their use as anti-inflammatory agents
TW200901961A (en) * 2007-02-16 2009-01-16 Synta Pharmaceuticals Corp Substituted fused-ring compounds for inflammation and immune-related uses
EP2072509A1 (en) 2007-12-18 2009-06-24 Bayer Schering Pharma Aktiengesellschaft 1-Aryl-1H-quinoline-2-ones: process for their production and their use as anti-inflammatory agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2208844A1 (en) * 1994-12-29 1996-07-11 Alan T. Johnson Acetylenes disubstituted with a 5 or 8 substituted tetrahydronaphthyl or dihydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity
DE10038639A1 (en) * 2000-07-28 2002-02-21 Schering Ag New and known N-aryl 2-hydroxy-omega-arylalkanamide derivatives, useful e.g. for treating inflammatory diseases such as rheumatism
DE60318188T2 (en) * 2002-03-26 2008-12-11 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield GLUCOCORTICOID MIMETICS, THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS AND USE
DE10215316C1 (en) * 2002-04-02 2003-12-18 Schering Ag Quinoline and isoquinoline derivatives, a pharmaceutical agent and their use as anti-inflammatory agents
DE502004002403D1 (en) * 2003-10-08 2007-02-01 Schering Ag TETRAHYDRONAPHTHALIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS AN INFLAMMATORY INHIBITION

Also Published As

Publication number Publication date
TW200621703A (en) 2006-07-01
AR050733A1 (en) 2006-11-15
KR20070050469A (en) 2007-05-15
AU2005281859A1 (en) 2006-03-16
ZA200701399B (en) 2008-09-25
ATE384069T1 (en) 2008-02-15
DE502005002595D1 (en) 2008-03-06
RS20070095A (en) 2008-11-28
WO2006027236A1 (en) 2006-03-16
PE20060596A1 (en) 2006-07-26
IL181832A0 (en) 2007-07-04
GT200500241A (en) 2006-08-17
CN101065386A (en) 2007-10-31
EP1786823B1 (en) 2008-01-16
BRPI0515186A (en) 2008-07-22
EA200700550A1 (en) 2007-10-26
MX2007002833A (en) 2007-07-09
DE102004044680B3 (en) 2006-06-08
ES2301056T3 (en) 2008-06-16
EP1786823A1 (en) 2007-05-23
ECSP077306A (en) 2007-04-26
UY29109A1 (en) 2006-03-31
CA2577861A1 (en) 2006-03-16
PA8644701A1 (en) 2006-07-03
SV2006002220A (en) 2006-03-15
JP2008512416A (en) 2008-04-24

Similar Documents

Publication Publication Date Title
NO20090628L (en) Pyridizinone derivatives
NO20072963L (en) 5-substituted quinoline and isoquinoline derivatives, process for their preparation and their use as inflammatory inhibitors
NO20083427L (en) Cystotoxic agents comprising novel tomaymycin derivatives and their therapeutic use
NO20044731L (en) Quinoline and Isoquinoline Derivatives Process for Preparation thereof and its Use as Inflammatory Inhibitors
NO20071593L (en) pyrimidine
NO20091553L (en) Phenyl derivatives and their use as immunomodulators
NO20071805L (en) Alkylidentetrahydronaphthalene derivatives, processes for their preparation and their use as inflammatory inhibitors.
NO20073791L (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
NO20066055L (en) pyridine derivatives
NO20082090L (en) Pyridopyrimidinone inhibitors of P13K alpha
NO20073859L (en) Pyrrolopyrazoles, potent kinase inhibitors
NO20081636L (en) FAP inhibitors
NO20076648L (en) Novel thiophene derivatives
NO20070224L (en) 2-urea-4-phenylthiazole derivatives, preparation and therapeutic use thereof
NO20074666L (en) Imidazo (1,2-A) pyridine compounds as VEGF-R2 inhibitors
NO20061157L (en) 4-pyramidone derivatives and their use as peptidyl peptide inhibitors
NO20080675L (en) P38-Map kinase inhibitors and methods for their use
NO20071242L (en) Triazole pyridinylsulfanyl derivatives as P38-MAP kinase inhibitors
EA200501928A1 (en) Pyrrolodihydroisoquinols as inhibitors of PDE10
EA200601391A1 (en) QUINOLINE DERIVATIVES FOR USE AS MYCOBACTERIAL INHIBITORS
NO20083708L (en) 4-Phenyl-thiazole-5-carboxylic acid and 4-phenyl-thiazole-5-carboxylmides as PLK1 inhibitors
NO20062020L (en) 1-Amino-2-Oxy-Substituted Tetrahydronaphthalene Derivatives, Methods of Preparation thereof, and Their Use as Antiflogistics
NO20084301L (en) Tetrahydronaphthalene derivatives, processes for their preparation and their use as anti-inflammatory agents
EA200801608A1 (en) DERIVATIVES OF BENZIMIDAZOLONIC CARBONIC ACID
NO20062021L (en) Redirected pentanols, their methods of preparation, and their use as antiflogistics

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application